HBIO (Harvard Bioscience, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 21.45 million USD with EPS (earnings per share) anticipated at (0.21) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported20.45 M20.59 M23.73 M20.75 M— | Revenue Estimate18.75 M20.00 M23.10 M21.20 M21.45 M | Revenue Surprise+9.07%+2.96%+2.75%-2.10% | EPS Reported(0.10)0.000.00(0.33) | EPS Estimate(0.25)0.050.35(0.62)(0.21) | EPS Surprise+60.00%-100.00%-100.00%+46.77% |